BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18562185)

  • 21. Palliative radiotherapy in prostate cancer.
    Catton CN; Gospodarowicz MK
    Semin Urol Oncol; 1997 Feb; 15(1):65-72. PubMed ID: 9050141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic.
    Kirou-Mauro AM; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E
    J Pain Symptom Manage; 2009 Jan; 37(1):77-84. PubMed ID: 18504094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study.
    Hird A; Zhang L; Holt T; Fairchild A; DeAngelis C; Loblaw A; Wong R; Barnes E; Tsao M; Danjoux C; Chow E
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):329-35. PubMed ID: 19232483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction.
    Foro Arnalot P; Fontanals AV; Galcerán JC; Lynd F; Latiesas XS; de Dios NR; Castillejo AR; Bassols ML; Galán JL; Conejo IM; López MA
    Radiother Oncol; 2008 Nov; 89(2):150-5. PubMed ID: 18556080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is response to radiotherapy in patients related to the severity of pretreatment pain?
    Kirou-Mauro A; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1208-12. PubMed ID: 18572084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on radiation treatment for cancer pain.
    Chow E
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):11-5. PubMed ID: 18660718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When should we define the response rates in the treatment of bone metastases by palliative radiotherapy?
    Li KK; Hadi S; Kirou-Mauro A; Chow E
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):83-9. PubMed ID: 17981445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Samarium-153 treatment of bone pain in patients with metastatic prostate cancer.
    Petersen LJ; Lund L; Jønler M; Jakobsen M; Abrahamsen J
    Dan Med Bull; 2010 Jun; 57(6):A4154. PubMed ID: 20515602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions.
    Lee IJ; Seong J; Lee CG; Kim YB; Keum KC; Suh CO; Kim GE; Cho J
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1517-24. PubMed ID: 19084348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative radiotherapy for bone metastases in the last 3 months of life: worthwhile or futile?
    Dennis K; Wong K; Zhang L; Culleton S; Nguyen J; Holden L; Jon F; Tsao M; Danjoux C; Barnes E; Sahgal A; Zeng L; Koo K; Chow E
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):709-15. PubMed ID: 21665446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.
    Macchia G; Ferro M; Cilla S; Buwenge M; Ianiro A; Boccardi M; Picardi V; Ferro M; Arena E; Zamagni A; Cammelli S; Valentini V; Morganti AG; Deodato F
    Clin Exp Metastasis; 2018 Dec; 35(8):747-752. PubMed ID: 30251079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-body irradiation: a safe and acceptable treatment.
    Miszczyk L; Gaborek A; Tukiendorf A; Jochymek B; Wydmański J
    Med Sci Monit; 2009 Jun; 15(6):CR319-24. PubMed ID: 19478704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma.
    Lee J; Hodgson D; Chow E; Bezjak A; Catton P; Tsuji D; O'Brien M; Danjoux C; Hayter C; Warde P; Gospodarowicz MK
    Cancer; 2005 Nov; 104(9):1894-900. PubMed ID: 16177996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.
    Tang CI; Loblaw DA; Cheung P; Holden L; Morton G; Basran PS; Tirona R; Cardoso M; Pang G; Gardner S; Cesta A
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):729-37. PubMed ID: 18838256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?
    Harris K; Li K; Flynn C; Chow E
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):523-7. PubMed ID: 17566723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.
    Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S
    J BUON; 2009; 14(2):245-9. PubMed ID: 19650174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of palliative and symptomatic radiotherapy in bone metastasis].
    Tordiglione M; Luraghi R; Antognoni P
    Radiol Med; 1999 May; 97(5):372-7. PubMed ID: 10432969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14.
    Konski A; Desilvio M; Hartsell W; Watkins-Bruner D; Coyne J; Scarantino C; Janjan N
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):229-33. PubMed ID: 16814950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.